Trial Profile
A Prospective, Open-label 96-week Observational Pilot Study to Compare the Safety of Efavirenz Versus Nevirapine (Each in Combination With Zidovudine and Lamivudine or Tenofovir and Lamivudine) in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Lamivudine; Nevirapine; Tenofovir disoproxil fumarate; Zidovudine
- Indications HIV infections
- Focus Adverse reactions
- 18 Jan 2011 New trial record